Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Early cervical cancer.

K H Lu1, T W Burke

  • 1Department of Gynecologic Oncology, M.D. Anderson Cancer Center, Box 67, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II study.

American journal of obstetrics and gynecology·2025
Same author

[Early results of modified Bikini approach periacetabular osteotomy for the treatment of developmental hip dysplasia under 50 years of age].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2023
Same author

Phase I-II clinical trial design: a state-of-the-art paradigm for dose finding.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Comparison of Mitochondrial Function in Boar and Bull Spermatozoa Throughout Cryopreservation Based on JC-1 Staining.

Cryo letters·2017
Same author

Derivation and characterization of primordial germ cells from Guangxi yellow-feather chickens.

Poultry science·2017
Same author

Isolation, proliferation, and induction of Bama mini-pig spermatogonial stem cells in vitro.

Genetics and molecular research : GMR·2016
Same journal

Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs.

Current treatment options in oncology·2026
Same journal

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Current treatment options in oncology·2026
Same journal

Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review.

Current treatment options in oncology·2026
Same journal

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Current treatment options in oncology·2026
Same journal

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.

Current treatment options in oncology·2026
Same journal

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research.

Current treatment options in oncology·2026
See all related articles

Early cervical cancer treatment varies by stage. For stage IA, conservative management or surgery is used. Stage IB1 involves surgery or radiation, with chemotherapy improving survival for advanced cases.

Area of Science:

  • Gynecologic Oncology
  • Radiation Oncology
  • Medical Oncology

Background:

  • Early cervical cancer encompasses a spectrum from microinvasive to bulky tumors.
  • The International Federation of Gynecology and Obstetrics (FIGO) staging system categorizes stage I into IA (microinvasive) and IB (gross tumor).
  • Optimal treatment for early cervical cancer requires precise subgrouping.

Purpose of the Study:

  • To outline the current management strategies for early-stage cervical cancer (FIGO stage I).
  • To discuss treatment controversies and decision-making factors for stage IA and IB1 cervical cancer.
  • To highlight the role of chemotherapy in improving survival rates.

Main Methods:

  • Review of current clinical practices and staging criteria for early cervical cancer.

Related Experiment Videos

  • Analysis of treatment outcomes for surgery versus radiotherapy in stage IB1 disease.
  • Evaluation of the impact of adjuvant chemotherapy on survival.

    • Main Results:

    • Stage IA management varies, with simple hysterectomy or cone biopsy for fertility preservation.
    • Patients with >3 mm invasion or lymphovascular involvement require radical surgery and lymphadenectomy.
    • Stage IB1 tumors (<4 cm) are treated with radical surgery or radiotherapy; larger tumors (>4 cm) or those intolerant to surgery receive primary radiation.
    • Cisplatin-based chemotherapy significantly improves survival rates when added to radiation therapy.

    Conclusions:

    • Treatment decisions for early cervical cancer depend on tumor size, invasion depth, lymphovascular space involvement, and patient factors.
    • Radical surgery offers fertility preservation and avoids radiation side effects for select patients.
    • Chemotherapy, particularly cisplatin-based regimens, is crucial for improving survival in advanced early-stage cervical cancer.